[{"address1": "50 rue de Dijon", "city": "Daix", "zip": "21121", "country": "France", "phone": "33 3 80 44 75 00", "website": "https://inventivapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-\u00df, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.", "fullTimeEmployees": 84, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pierre  Broqua Ph.D.", "age": 62, "title": "Co-Founder", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 429274, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martine  Zimmermann Pharm.D.", "age": 55, "title": "Executive VP of Regulatory Affairs & Quality Assurance", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 69853, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Obenshain", "age": 50, "title": "CEO & Director", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean  Volatier", "age": 59, "title": "Deputy GM & CFO", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alice  Roudot-Ketelers Pharm.D.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Duranson L.L.M.", "age": 50, "title": "General Counsel", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nathalie  Harroy", "age": 57, "title": "Head of Human Resources", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pascaline  Clerc Ph.D.", "age": 44, "title": "Executive Vice President of Strategy & Corporate Affairs", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason A. Campagna M.D., Ph.D.", "age": 58, "title": "President of Research and Development & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.18, "open": 4.18, "dayLow": 4.05, "dayHigh": 4.21, "regularMarketPreviousClose": 4.18, "regularMarketOpen": 4.18, "regularMarketDayLow": 4.05, "regularMarketDayHigh": 4.21, "payoutRatio": 0.0, "beta": 0.775, "volume": 147926, "regularMarketVolume": 147926, "averageVolume": 235450, "averageVolume10days": 159540, "averageDailyVolume10Day": 159540, "bid": 4.15, "ask": 4.21, "bidSize": 1, "askSize": 1, "marketCap": 796635520, "fiftyTwoWeekLow": 2.111, "fiftyTwoWeekHigh": 7.983, "allTimeHigh": 19.064, "allTimeLow": 1.53, "priceToSalesTrailing12Months": 46.943756, "fiftyDayAverage": 4.831, "twoHundredDayAverage": 3.9475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 584979776, "forwardPE": -2.6399899, "profitMargins": 0.0, "floatShares": 61971020, "sharesOutstanding": 191017947, "sharesShort": 285615, "sharesShortPriorMonth": 288844, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.002, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.07407, "shortRatio": 0.67, "shortPercentOfFloat": 0.0022, "impliedSharesOutstanding": 192889953, "bookValue": -0.064, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -311064992, "trailingEps": -4.38, "enterpriseToRevenue": 34.471, "enterpriseToEbitda": -6.107, "52WeekChange": 0.60831094, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 4.13, "targetHighPrice": 26.0, "targetLowPrice": 3.0, "targetMeanPrice": 15.33333, "targetMedianPrice": 14.0, "recommendationMean": 1.11111, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 122513000, "totalCashPerShare": 0.88, "ebitda": -95789000, "totalDebt": 132798000, "quickRatio": 2.486, "currentRatio": 2.956, "totalRevenue": 16970000, "revenuePerShare": 0.192, "returnOnAssets": -0.56769, "grossProfits": 16153000, "freeCashflow": -77385752, "operatingCashflow": -91311000, "revenueGrowth": 1.052, "grossMargins": 0.95185995, "ebitdaMargins": 0.0, "operatingMargins": -9.91889, "financialCurrency": "EUR", "symbol": "IVA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1594387800000, "regularMarketChange": -0.0499997, "regularMarketDayRange": "4.05 - 4.21", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 235450, "fiftyTwoWeekLowChange": 2.019, "fiftyTwoWeekLowChangePercent": 0.95641875, "fiftyTwoWeekRange": "2.111 - 7.983", "fiftyTwoWeekHighChange": -3.8529997, "fiftyTwoWeekHighChangePercent": -0.4826506, "fiftyTwoWeekChangePercent": 60.831093, "corporateActions": [], "regularMarketTime": 1764968401, "exchange": "NGM", "messageBoardId": "finmb_273516426", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.19617, "regularMarketPrice": 4.13, "marketState": "CLOSED", "shortName": "Inventiva S.A. - American Depos", "longName": "Inventiva S.A.", "earningsTimestamp": 1759149000, "earningsTimestampStart": 1759149000, "earningsTimestampEnd": 1759149000, "earningsCallTimestampStart": 1743076800, "earningsCallTimestampEnd": 1743076800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.38, "epsCurrentYear": -2.014, "priceEpsCurrentYear": -2.0506456, "fiftyDayAverageChange": -0.70099974, "fiftyDayAverageChangePercent": -0.14510448, "twoHundredDayAverageChange": 0.18250012, "twoHundredDayAverageChangePercent": 0.046231825, "priceToBook": -64.53125, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-10", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "displayName": "Inventiva", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]